Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Magnussen

Showing results (51-60 of 408) with videos related to

Pageof 41
Sort By:
Schriftenreihe Des Vereins Fur Wasser-, Boden- Und Lufthygiene|January 1, 1988
[The significance of inhaled pollutants for bronchial asthma and chronic bronchitis]R Jörres, H Magnussen
Pneumologie (Stuttgart, Germany)|August 1, 1994
[Environmental pollutants and allergens: combination effects]H Magnussen, R Jörres
The European Respiratory Journal|September 1, 1992
Influence of short-term passive smoking on symptoms, lung mechanics and airway responsiveness in asthmatic subjects and healthy controlsR Jörres, H Magnussen
Medizinische Klinik (Munich, Germany : 1983)|November 20, 1987
[Fibrosing lung diseases--prognosis and therapy]G Kanzow, H Magnussen
The European Respiratory Journal|February 1, 1990
Airways response of asthmatics after a 30 min exposure, at resting ventilation, to 0.25 ppm NO2 or 0.5 ppm SO2R Jörres, H Magnussen
Pneumonologie. Pneumonology|May 30, 1975
Intrapulmonary gas mixing in man studied by dilution of inert gases of different diffusivityH Magnussen, P Scheid
The European Respiratory Journal|May 1, 1988
Spontaneous changes of airway hyperresponsiveness in bronchial asthmaH Magnussen, D Nowak
Deutsche Medizinische Wochenschrift (1946)|August 30, 1985
[Bronchodilator effect of fenoterol aerosol. Are 4 0.1-mg doses better than a single dose of 0.4 mg?]H Magnussen, M Fontani
Respiration; International Review of Thoracic Diseases|January 1, 1981
Intrapulmonary gas transport of He and SF6 in healthy subjects and patients with chronic obstructive lung diseaseH Magnussen, U Smidt
Medizinische Klinik (Munich, Germany : 1983)|June 15, 1991
[The effect of oral N-acetylcysteine on glutathione concentration in bronchoalveolar lavage of patients with fibrosing lung diseases]A Meyer, H Magnussen
Pageof 41

Showing results (51-60 of 408) with videos related to

Sort By:
Pageof 41
Schriftenreihe Des Vereins Fur Wasser-, Boden- Und Lufthygiene|January 1, 1988
[The significance of inhaled pollutants for bronchial asthma and chronic bronchitis]R Jörres, H Magnussen
Pneumologie (Stuttgart, Germany)|August 1, 1994
[Environmental pollutants and allergens: combination effects]H Magnussen, R Jörres
The European Respiratory Journal|September 1, 1992
Influence of short-term passive smoking on symptoms, lung mechanics and airway responsiveness in asthmatic subjects and healthy controlsR Jörres, H Magnussen
Medizinische Klinik (Munich, Germany : 1983)|November 20, 1987
[Fibrosing lung diseases--prognosis and therapy]G Kanzow, H Magnussen
The European Respiratory Journal|February 1, 1990
Airways response of asthmatics after a 30 min exposure, at resting ventilation, to 0.25 ppm NO2 or 0.5 ppm SO2R Jörres, H Magnussen
Pneumonologie. Pneumonology|May 30, 1975
Intrapulmonary gas mixing in man studied by dilution of inert gases of different diffusivityH Magnussen, P Scheid
The European Respiratory Journal|May 1, 1988
Spontaneous changes of airway hyperresponsiveness in bronchial asthmaH Magnussen, D Nowak
Deutsche Medizinische Wochenschrift (1946)|August 30, 1985
[Bronchodilator effect of fenoterol aerosol. Are 4 0.1-mg doses better than a single dose of 0.4 mg?]H Magnussen, M Fontani
Respiration; International Review of Thoracic Diseases|January 1, 1981
Intrapulmonary gas transport of He and SF6 in healthy subjects and patients with chronic obstructive lung diseaseH Magnussen, U Smidt
Medizinische Klinik (Munich, Germany : 1983)|June 15, 1991
[The effect of oral N-acetylcysteine on glutathione concentration in bronchoalveolar lavage of patients with fibrosing lung diseases]A Meyer, H Magnussen
Pageof 41